Thursday, April 18, 2024
ADVT 
Health

Safe injection sites may curb opioid deaths, report suggests

Darpan News Desk The Canadian Press, 08 Jul, 2020 09:05 PM
  • Safe injection sites may curb opioid deaths, report suggests

A safe haven in the U.S. where people can give themselves heroin and other drugs has observed more than 10,500 injections over five years and treated 33 overdoses with none proving fatal, researchers reported Wednesday.

The injection site is unsanctioned and its location hasn’t been revealed. The researchers say the results, published in the New England Journal of Medicine, show the potential for such places to curb deaths from the opioid epidemic.

Every year in the United States, nearly 70,000 people die of a drug overdose. Quick treatment with the medicine naloxone can prevent death in many cases. Besides offering trained staff to administer it, these injection sites offer safe disposal of used needles and a chance to get users into counselling and help with other health problems.

At least a dozen countries including Canada and many in Europe offer such sites. U.S. cities including Seattle, Boston and Philadelphia have been debating allowing them.

The unofficial one described in the medical journal opened in September 2014. Alex Kral, a San Francisco-based researcher with the research organization RTI International, and Peter Davidson, a medical sociologist at the University of Southern California, San Diego, reported on its five-year results.

As a condition of doing research there, they agreed to keep secret the location of the site and the name of the social service agency that runs it.

They previously described it as having two rooms, one with stainless steel stations that are cleaned and another next door where staff can monitor users afterward. The users bring their own drugs.

MORE Health ARTICLES

Serious coronavirus-linked condition hit 285 US children

Serious coronavirus-linked condition hit 285 US children
At least 285 U.S. children have developed a serious inflammatory condition linked to the coronavirus and while most recovered, the potential for long-term or permanent damage is unknown, two new studies suggest.

Serious coronavirus-linked condition hit 285 US children

Tattoo artist sees bump in desire to erase hateful skin art

Tattoo artist sees bump in desire to erase hateful skin art
A Vermont tattoo artist who has long offered free removal or covering of hateful skin art like swastikas, SS lightning bolts or the words “white power” says he’s seen an uptick in business recently following George Floyd's death.

Tattoo artist sees bump in desire to erase hateful skin art

Travellers to NY, New Jersey, Connecticut are told to isolate

Travellers to NY, New Jersey, Connecticut are told to isolate
New York, Connecticut and New Jersey will require visitors from states with high infection rates to quarantine for 14 days, New York Gov. Andrew Cuomo said Wednesday.

Travellers to NY, New Jersey, Connecticut are told to isolate

Open wide: US dentists quickly rebuild after virus shutdown

Open wide: US dentists quickly rebuild after virus shutdown
U.S. dental offices are quickly bouncing back, but it won't be business as usual. Expect social distancing, layers of protective gear and a new approach to some procedures to guard against coronavirus.

Open wide: US dentists quickly rebuild after virus shutdown

Virus cases surging among the young, endangering the elderly

Virus cases surging among the young, endangering the elderly
Coronavirus cases are climbing rapidly among young adults in a number of states where bars, stores and restaurants have reopened — a disturbing generational shift that not only puts them in greater peril than many realize but poses an even bigger danger to older people who cross their paths.

Virus cases surging among the young, endangering the elderly

Vancouver biotech company discovering antibodies for COVID-19 treatment

Vancouver biotech company discovering antibodies for COVID-19 treatment
There may be another valuable shield in the fight against COVID-19, and the head of a Vancouver biotech firm says it could buy time as researchers race to develop a vaccine. Carl Hansen, CEO of AbCellera Biologics Inc., said a drug built with antibodies could be used to protect vulnerable populations until a vaccine is more widely available.    

Vancouver biotech company discovering antibodies for COVID-19 treatment